Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Chronic Obstructive Pulmonary Disease
100%
Beta-blockers
100%
Patients with Heart Failure
100%
Asian Patients
100%
Reduced Ejection Fraction
33%
Japan
22%
South Asia
22%
Asia
22%
Disease Groups
22%
Northeast Asia
22%
China
11%
India
11%
Heart Failure
11%
Ethnic Groups
11%
Indonesia
11%
Low-income
11%
Heart Failure Therapy
11%
Treatment Strategy
11%
Singapore
11%
South-East Asia
11%
Taiwan
11%
Hong Kong
11%
South Korea
11%
Clinical Characteristics
11%
Thailand
11%
Philippines
11%
Clinical Treatment
11%
Income Level
11%
Filipino
11%
Diuretics
11%
Chronic Obstructive Pulmonary Disease Patient
11%
High-income
11%
Japanese Population
11%
Mineralocorticoid Receptor Antagonists
11%
Underuse
11%
Propensity Matching
11%
Malaysia
11%
Asian Region
11%
Regional Income
11%
Characteristics Approach
11%
Propensity-matched Cohort
11%
Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
100%
Congestive Heart Failure
100%
Ejection Fraction
30%
Prevalence
20%
Ethnic Groups
10%
Mineralocorticoid Antagonist
10%
5 Hydroxy 2 (N Phenethyl N Propylamino)tetralin
10%
Diuretics
10%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Congestive Heart Failure
100%
Prevalence
20%
Mineralocorticoid Antagonist
10%
5 Hydroxy 2 (N Phenethyl N Propylamino)tetralin
10%
Diuretics
10%